ARTICLE | Company News
Anacor, GlaxoSmithKline deal
August 9, 2010 7:00 AM UTC
GlaxoSmithKline exercised an option to license exclusive, worldwide rights from Anacor to develop and commercialize GSK2251052 (formerly AN3365), a boron-based, small-molecule antibiotic targeting th...